Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.47 |
| ▸ | GJB2 | P29033 | 4/20 | 0.47 |
| ▸ | MDM4 | O15151 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.45 |
| ▸ | LGALS3 | P17931 | 4/20 | 0.44 |
| ▸ | LGALS7; LGALS7B | P47929 | 2/20 | 0.43 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.43 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.43 |
| ▸ | MAG | P20916 | 1/20 | 0.42 |
| ▸ | TACR2 | P21452 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | GJA1 | P17302 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | NT5E | P21589 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25913933 | 0.87 | GJB2 (0.48) | GJB2SLC6A2GJA1NT5E | |
| SCHEMBL15516519 | 0.87 | TP53 (0.55) | TP53MDM2MDM4HSP90AA1HSP90AB1 | |
| SCHEMBL6553315 | 0.86 | LGALS3 (0.47) | TP53MDM2LGALS3LGALS7; LGALS7BLGALS1 | |
| SCHEMBL11494535 | 0.86 | MAG (0.49) | TP53MDM2LGALS3LGALS7; LGALS7BLGALS1 | |
| SCHEMBL10704820 | 0.86 | GJB2 (0.51) | TP53MDM2GJB2MDM4HSP90AA1 | |
| SCHEMBL11170198 | 0.86 | MAG (0.49) | TP53MDM2LGALS3LGALS7; LGALS7BLGALS1 | |
| SCHEMBL11170193 | 0.86 | MAG (0.49) | TP53MDM2LGALS3LGALS7; LGALS7BLGALS1 | |
| SCHEMBL18867223 | 0.85 | LMNA (0.52) | TP53MDM2GJB2MDM4HSP90AA1 | |
| SCHEMBL7774709 | 0.84 | MAPK1 (0.50) | TP53MDM2MDM4HSP90AA1HSP90AB1 | |
| SCHEMBL25913950 | 0.84 | LMNA (0.54) | TP53MDM2MDM4HSP90AA1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218766-A1 | SUGAR COMPOUND HAVING POLYETHYLENE GLYCOL CHAIN, AND PRECURSOR OF ANTIBODY-DRUG COMPLEX | THE NOGUCHI INSTITUTE (JP) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218766-A1 | SUGAR COMPOUND HAVING POLYETHYLENE GLYCOL CHAIN, AND PRECURSOR OF ANTIBODY-DRUG COMPLEX | FCGRT, HBZ, FUT4 | TP53 3889/4885MDM2 4657/4885GJB2 2030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.